FAGRON N.V. |
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 17,7 EUR | -1,12 % |
|
+0,34 % | +6,56 % |
Resumen de negocios
Número de empleados: 3 282
Ventas por actividad
| EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Fagron North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99 % |
Fagron EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08 % |
Fagron Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25 % |
Ventas por región
| EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99 % |
EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08 % |
Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
| Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Karen Berg
IRC | Investor Relations Contact | - | 01/09/21 |
Marc van der Aa
PRN | Corporate Officer/Principal | - | - |
Johan Verlinden
LAW | General Counsel | - | 01/04/13 |
| Corporate Officer/Principal | 54 | 01/01/08 | |
Celine Caveye
HRO | Human Resources Officer | - | 01/01/11 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Koen Hoffman
CHM | Chairman | 56 | 01/08/16 |
| Director/Board Member | 64 | 01/01/19 | |
| Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
| Director/Board Member | 53 | 09/05/22 | |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Neeraj Sharma
BRD | Director/Board Member | 52 | 09/05/22 |
| Director/Board Member | 52 | 01/01/22 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 73 228 904 | 69 227 472 ( 94,54 %) | 241 999 ( 0,3305 %) | 94,54 % |
Información de la empresa
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
FAGRON as
 FAGRON as Pharmaceuticals: MajorHealth Technology FAGRON as operates as wholesaler of pharmaceutical raw materials, creams and packaging to pharmacists. The company was founded on May 11, 1992 and is headquartered in Olomouc, Czech Republic. |
Pharmaceuticals: Major
|
Arseus Capital NV
 Arseus Capital NV Financial ConglomeratesFinance Part of Fagron NV, Arseus Capital NV provides financial services. The private company is based in Nazareth, Belgium. The CEO of the Belgian company is Cornelia de Jong. |
Financial Conglomerates
|
Dr. Kulich Pharma sro
 Dr. Kulich Pharma sro Pharmaceuticals: MajorHealth Technology Dr. Kulich Pharma sro engages in the pharmaceuticals industry. It offers drugs, pharmaceutical materials, chemicals, as well as laboratory services. The company was founded by Jan Kulich in 1992 and is headquartered in Hradec Kralove, Czech Republic. |
Pharmaceuticals: Major
|
Fagron BV
|
Ventas por actividad
Ventas por región
Calificación trading
Calificación Inversor
ESG Refinitiv
B
Venta
Compra
Recomendación promedio
COMPRAR
Numero de análisis
5
Último precio de cierre
17,7
EUR
Precio objetivo promedio
21,5
EUR
Diferencia / Objetivo Promedio
+21,47 %
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +6,56 % | 1390 M | |
| +27,97 % | 676 mil M | |
| +23,58 % | 554 mil M | |
| -7,02 % | 349 mil M | |
| +14,85 % | 318 mil M | |
| +6,25 % | 291 mil M | |
| +2,96 % | 210 mil M | |
| -0,41 % | 204 mil M | |
| -10,02 % | 194 mil M | |
| -11,81 % | 144 mil M |
- Bolsa de valores
- Acciones
- Acción FAGR
- Empresa Fagron N.V.
